AU2001272452A1 - Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency - Google Patents

Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency

Info

Publication number
AU2001272452A1
AU2001272452A1 AU2001272452A AU7245201A AU2001272452A1 AU 2001272452 A1 AU2001272452 A1 AU 2001272452A1 AU 2001272452 A AU2001272452 A AU 2001272452A AU 7245201 A AU7245201 A AU 7245201A AU 2001272452 A1 AU2001272452 A1 AU 2001272452A1
Authority
AU
Australia
Prior art keywords
gel
oxygen
preparation
regeneration
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272452A
Other languages
English (en)
Inventor
Wolfgang Barnikol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beil Hans Hansmann And Vogeser
Original Assignee
HANS HANSMANN AND VOGESER BEIL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANS HANSMANN AND VOGESER BEIL filed Critical HANS HANSMANN AND VOGESER BEIL
Publication of AU2001272452A1 publication Critical patent/AU2001272452A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
AU2001272452A 2000-06-29 2001-06-02 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency Abandoned AU2001272452A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10031741.3 2000-06-29
DE10031741A DE10031741A1 (de) 2000-06-29 2000-06-29 Einen Sauerstoffträger, ausgewählt aus Hämoglobin oder Hämoglobin- und Myoglobin-enthaltende Zubereitung als Externum zur natürlichen Regeneration der Haut bei Sauerstoff-Mangel
PCT/EP2001/006328 WO2002000246A2 (de) 2000-06-29 2001-06-02 Sauerstoffträger enthaltende zubereitung zur regeneration der haut bei sauerstoff-mangel

Publications (1)

Publication Number Publication Date
AU2001272452A1 true AU2001272452A1 (en) 2002-01-08

Family

ID=7647245

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272452A Abandoned AU2001272452A1 (en) 2000-06-29 2001-06-02 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency

Country Status (7)

Country Link
US (1) US20030180365A1 (es)
EP (1) EP1303297B1 (es)
AT (1) ATE282427T1 (es)
AU (1) AU2001272452A1 (es)
DE (2) DE10031741A1 (es)
ES (1) ES2232645T3 (es)
WO (1) WO2002000246A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10212321A1 (de) * 2002-03-20 2003-10-09 Sanguibio Tech Ag Verwendung eines oder mehrerer von Plasma und Zellwandbestandteilen befreiten natürlichen oder modifizierten Sauerstoffbinder zur externen Behandlung offener, insbesondere chronischer Wunden
DE10342449A1 (de) * 2003-09-13 2005-04-07 Beiersdorf Ag Verwendung von Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
ES2612752T3 (es) * 2003-12-18 2017-05-18 Metronom Health, Inc. Biosensor implantable y métodos de uso del mismo
DE10360503A1 (de) * 2003-12-22 2005-07-14 Sanguibiotech Gmbh Kombinations- Set und Verfahren zur bioregenerativen Behandlung von Haut
DE102004001266A1 (de) * 2004-01-07 2005-08-18 Beiersdorf Ag Haarwuchs fördernde Zubereitungen mit proteinogenen Sauerstoffträgern
FR2917292B1 (fr) * 2007-06-18 2014-06-13 Centre Nat Rech Scient Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
DK2661275T3 (en) * 2011-01-07 2019-04-15 Poseida Therapeutics Inc COMPOSITIONS AND METHODS FOR ADMINISTRATING THE HIGH OXYGEN EFFICIENCY TO TUMORS FOR THE ADMINISTRATION
ES2432075T3 (es) * 2011-07-23 2013-11-29 Sastomed Gmbh Espray para heridas
US10729748B2 (en) 2012-01-13 2020-08-04 Mölnlycke Health Care Ab Scarring reducing wound treatment
EP2614833A1 (en) * 2012-01-13 2013-07-17 SastoMed GmbH Scarring reducing wound treatment
US10456452B2 (en) 2015-07-02 2019-10-29 Poseida Therapeutics, Inc. Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
KR20180059800A (ko) 2015-09-02 2018-06-05 메트로놈 헬스, 인크. 옵토-효소 분석물 센서를 이용하는 연속 건강 모니터링 시스템 및 방법
CA3013349A1 (en) * 2016-02-08 2017-08-17 Hackensack University Medical Center Compositions and methods for treating chronic wounds
US9977258B2 (en) * 2016-04-14 2018-05-22 Johnson & Johnson Vision Care, Inc. Methods and apparatus to enhance oxygen concentrations for ophthalmic devices
EP3449004B1 (en) 2016-04-29 2021-02-24 Poseida Therapeutics, Inc. Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids
EP3421044A1 (en) * 2017-06-26 2019-01-02 SastoMed GmbH Oxygen carriers for the treatment of skin indispositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2527210A (en) * 1944-01-25 1950-10-24 John O Bower Hemoglobin solution and method
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
FR2641463B1 (fr) * 1989-01-09 1991-03-08 Sederma Sa Preparations cosmetiques destinees a l'oxygenation de la peau
US5386014A (en) * 1989-11-22 1995-01-31 Enzon, Inc. Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
US5312808A (en) * 1989-11-22 1994-05-17 Enzon, Inc. Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
US5439882A (en) * 1989-12-29 1995-08-08 Texas Tech University Health Sciences Center Blood substitute
US5248785A (en) * 1990-02-12 1993-09-28 Virginia Commonwealth University Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
FR2717385B1 (fr) * 1994-03-21 1996-04-19 Oreal Composition cosmétique contenant en association une superoxyde dismutase et une porphyrine.
WO1997015313A1 (en) * 1995-10-26 1997-05-01 Baxter International Inc. Therapeutic use of hemoglobin in promoting wound healing
FR2741266A1 (fr) * 1995-11-16 1997-05-23 Chassignole Jean Bernard Stimulation du metabolisme cellulaire par une proteine fixant reversiblement l'oxygene, celle-ci permettant la potentialisation de l'activite d'autres substances a vocation therapeutique ou cosmetique
CA2263411A1 (en) * 1996-08-12 1998-02-19 Eyal S. Ron Composition for pharmaceutical applications
DE19701037A1 (de) * 1997-01-15 1998-07-16 Sanguibiotech Ag Mit Schutzliganden der Sauerstoffbindungsstellen versehene Hämoglobine als künstliche Sauerstoffträger zur direkten biologisch-medizinischen Anwendung und Verfahren zu ihrer Herstellung
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
CA2463504C (en) * 2001-10-12 2013-02-19 Geo Trust, Inc. Methods and systems for automated authentication, processing and issuance of digital certificates
US20050076201A1 (en) * 2003-08-15 2005-04-07 Imcentric, Inc. System for discovering SSL-enabled network devices and certificates

Also Published As

Publication number Publication date
ES2232645T3 (es) 2005-06-01
EP1303297B1 (de) 2004-11-17
US20030180365A1 (en) 2003-09-25
EP1303297A2 (de) 2003-04-23
DE10031741A1 (de) 2002-01-17
DE50104553D1 (de) 2004-12-23
WO2002000246A3 (de) 2002-05-10
WO2002000246A8 (de) 2002-12-12
WO2002000246A2 (de) 2002-01-03
ATE282427T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
AU2001272452A1 (en) Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
CO4700482A1 (es) Formulaciones de un analogo monomero de insulina
CA2166480A1 (en) Cold sterilant with extended active life
ATE275378T1 (de) Wässrige kosmetische gele
EP0156354A3 (en) Controlled oxidation of microbially produced cysteine containing proteins
ATE430584T1 (de) Systeme und verfahren zur topischen behandlung mit stickstoffmonoxyd
DE59812766D1 (de) Lösung für die Peritonealdialyse
KR870008580A (ko) 항치석 치약
BG104020A (en) Pharmaceutical composition for mucous membrane application
US4781923A (en) Antiseptic gels
DE59902270D1 (de) Feuchtigkeitsaktivierbares therapeutisches system
KR101537774B1 (ko) 악취제거제 조성물 및 그 제조방법
ATE92303T1 (de) Periodontische zusammensetzung und verfahren.
AP1790A (en) Composition containing paraquat and/or diquat an alginate and an emetic and/or purgative.
MXPA03005931A (es) Composiciones estables para el cuidado de la piel conteniendo un retinoide y un sistema reforzador de retinoides.
GR3036481T3 (en) Medicament containing delta-aminolevulinic acid
TW200501968A (en) Agent for preventing and ameliorating constipation
DE69703548D1 (de) Glutaminhaltiges orales rehydrationsprodukt
DE60020871D1 (de) Formulierungen mit verlängerter freisetzung zur implantation
EP1071410B8 (fr) Composition aqueuse ionique contenant du levomenthol
RU97102782A (ru) Средство для терапии пародонтита
RU96124181A (ru) Гель лечебно-профилактический
MX9702505A (es) Geles de alginato.
RU2001120482A (ru) Средство для лечения гингивита
RU94002975A (ru) Препарат для массажа "малавит"